VC Ron Conway faces rare cancer, pledges to continue work at SV Angel during treatment.

Ron Conway, one of Silicon Valley's most influential venture capitalists, announced that he has been diagnosed with a rare form of cancer and is beginning treatment. According to reports, Conway revealed the diagnosis publicly and outlined a treatment plan expected to last roughly a year, while pledging to remain engaged with his work despite the health challenge.

Conway said he will be stepping back from some of his usual activities during his treatment period, according to TechCrunch. However, he indicated his commitment to continuing support for founders backed by his firm, SV Angel, signaling that the cancer diagnosis will not result in a complete withdrawal from his professional responsibilities. His announcement reflected an optimistic tone about his prognosis and determination to fight the disease.

The timing of Conway's disclosure comes as a significant development in tech industry circles. Conway has long been recognized as a major power broker and influential figure in venture capital, with extensive networks across Silicon Valley. His decision to publicly share his cancer diagnosis and treatment plans demonstrates a willingness to be transparent about his health situation while maintaining his professional commitments.

The rare nature of Conway's cancer diagnosis and the year-long treatment timeline he outlined suggest a serious medical situation, though details about the specific type of cancer and treatment protocols have not been fully disclosed. His commitment to remaining involved in supporting SV Angel's portfolio companies indicates his confidence in managing both his health and professional responsibilities during this period.